VistaGen Therapeutics (VTGN) PT Raised to $7 at Jefferies
Tweet
Share
E-mailGet Alerts VTGN Hot Sheet
Price: $0.27 --0%
Rating Summary:
2 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
2 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Jefferies analyst Andrew Tsai raised the price target on VistaGen Therapeutics (NASDAQ: VTGN) to $7.00 (from $6.00) while maintaining a Buy rating.
You May Also Be Interested In
- Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update
- Calian Group Ltd (CGY:CN) (CLNFF) PT Raised to Cdn$109 at Desjardins
- Diversified Royalty Corp (DIV:CN) (BEVFF) PT Lowered to Cdn$4.75 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
